A recurrent chromosomal abnormality associated with a subset of papillary renal cell carcinomas is t(X;1)(p11;q21). This translocation leads to the formation of two fusion genes, TFE3PRCC and the reciprocal product PRCCTFE3. Both fusion genes are expressed in t(X;1)-positive renal cell carcinomas and contain major parts of the coding regions of the parental transcription factor PRCC and TFE3 genes, respectively. To ®nd out whether these fusion genes possess transforming capacity, we transfected NIH3T3 and rat-1 cells with the fusion products, either separately or combined. When using soft agar assays, we observed colony formation in all cases. NIH3T3 cells transfected with PRCCTFE3 or PRCCTFE3 together with TFE3PRCC yielded the highest colony forming capacities. Examination of other characteristics associated with malignant transformation, i.e., growth under low-serum conditions and formation of tumors in athymic nude mice, revealed that cells transfected with PRCCTFE3 exhibited all these transformation-associated characteristics. Upon transfection of the fusion products into conditionally immortalized kidney cells, derived from the proximal tubules of an H2Kb-tsA58 transgenic mouse, and consecutive incubation under non-permissive conditions, growth arrest was observed, followed by dierentiation except for those cells transfected with PRCCTFE3. Therefore, we conclude that PRCCTFE3 may be the t(X;1)-associated fusion product that is most critical for the development of papillary renal cell carcinomas.
Introduction
In the last two decades ample evidence has been provided to show that speci®c chromosomal abnormalities play a crucial role in the development of the speci®c tumor type in which they occur (Rabbitts, 1994; Sorensen and Triche, 1996) . Renal cell cancers mostly show chromosome 3 abnormalities (Kovacs et al., 1988; van den Berg et al., 1993) . However, in a subset of renal cell carcinomas with chromophilic histology and mainly a papillary growth pattern, commonly referred to as papillary renal cell carcinomas, these abnormalities are absent. Instead, a combination of gain of chromosomes 7 and 17, and loss of the Y-chromosome has been reported (Meloni et al., 1993; van den Berg et al., 1993) . In a subset of these tumors, a recurring chromosomal translocation, t(X;1)(p11;q21), has been described, sometimes as the only cytogenetic abnormality present (de Jong et al., 1986) . Despite the limited amount of histologic information available on these tumors, there is growing evidence that this subgroup represents a separate entity characterized by a relatively low age of onset and a low male to female preponderance (Thoenes et al., 1986; Meloni et al., 1993; Tonk et al., 1995; Dijkhuizen et al., 1995; Hernandez-Marti et al., 1995; Carcao et al., 1998; Desangles et al., 1999; Perot et al., 1999) . Positional cloning of the genes involved in the t(X;1) translocation revealed that the TFE3 gene on the Xchromosome is fused to the PRCC gene on chromosome 1 (Weterman et al. 1996a,b; Sidhar et al., 1996) . Consequently, two reciprocal fusion genes are formed: TFE3PRCC and PRCCTFE3 encoding two putative fusion proteins. TFE3 is a ubiquitously expressed transcription factor which belongs to a superfamily of transcription factors characterized by a basic helix ± loop ± helix domain followed by a leucine zipper, both known to be involved in dimerization and DNA binding (Beckmann and Kadesch, 1991; Roman et al., 1992) . The PRCCTFE3 fusion protein contains these domains in addition to the N-terminal 156 amino acids of PRCC, which signi®cantly alter the transactivation capacity of the transcription factor (Weterman et al., 2000) . PRCC exhibits no signi®cant homologies to other known genes or proteins, and is characterized by a relatively high content of prolines. It is a ubiquitously expressed nuclear protein with transactivation capacity, suggesting a potential role in the regulation of gene expression (Weterman et al., 2000) . The reciprocal translocation product, TFE3PRCC, is composed of the N-terminal 178 amino acids of TFE3 and the C-terminal 335 amino acids of PRCC. This fusion protein is also located in the nucleus and shows a transactivation capacity comparable to that of PRCC. Both fusion genes are expressed in t(X;1)-positive renal cell carcinomas and, thus, may both play a role in the development of these tumors. In order to determine whether these fusion genes are capable of conferring transformation to other cell types, we transfected non-malignant NIH3T3 and rat-1 cells with expression constructs containing the corresponding fusion cDNAs. After transfection, several aspects associated with malignant transformation were evaluated for a number of transfectants such as anchorageindependent growth, growth under low-serum conditions, and the ability to form tumors in athymic nude mice. Finally, conditionally immortalized kidney cells derived from the proximal tubules of an H-2Kb-tsA58 transgenic mouse were transfected with expression constructs containing the fusion cDNAs after which these cells were transferred to non-permissive conditions to examine the eect of the fusion genes on growth and dierentiation of these cells.
Results

Anchorage-independent growth of PRCCTFE3-and TFE3PRCC-transfected cells
In order to determine the eect of the fusion genes on transformation, NIH3T3 and rat-1 cells were stably transfected with expression constructs containing full length PRCCTFE3 or TFE3PRCC cDNAs or both. As positive and negative controls cells transfected with an activated RAS allele or the empty vector were included, respectively. Since anchorage-independent growth is one of the characteristics of malignantly transformed cells, 50 000, 100 000 and 150 000 transfected cells were plated in duplo onto soft agar dishes. After 24 days, macroscopic colonies could be detected in all dishes containing rat-1 cells including the negative controls and in the dishes containing NIH3T3 cells transfected with the positive control construct. However, microscopic colonies could be observed in all other cases. The results of the microscopic counts are shown in Table 1 . For rat-1 cells, the highest numbers of colonies were detected after transfection with both constructs. When comparing the two translocation products, the TFE3PRCC transfection yielded higher numbers of colonies than the PRCCTFE3 transfection, although it has to be noted that dierences in plating eciencies were very small between negative and positive controls. For NIH3T3 transfectants PRCCTFE3 gave higher colony numbers than TFE3PRCC, although these were close to background numbers as counted for the negative control. The positive control (Leu61) clearly demonstrated a better colony forming eciency than any other NIH3T3 transfectant. Of these transfectants, the combination of both translocation products yielded the highest number of colonies although it has to be noted that these colonies were often smaller and more irregular in shape than the regular round colonies seen in the other transfectants (see also Figure 4 ). When plating only 50 000 cells, the plating eciency of the combination dropped 4 ± 5-fold (0.1% as compared to 0.4 and 0.5% for the higher number of cells). This eect was also observed for rat-1 cells albeit much less pronounced. To be able to compare the eects of each translocation product directly, both PRCCTFE3 and TFE3PRCC constructs were cloned into the same expression vector. Consequently, this excluded selection for the presence of both constructs. To prevent changes during the assays in the population of transfected cells and because plating eciencies were rather low, we chose to examine a number of colonies more closely. NIH3T3 cells were chosen since rat-1 cells also gave high colony numbers for the negative control. Individual colonies were picked when grown to macroscopically visible size and evaluated for: (i) morphology and growth pattern; (ii) expression level of the transfected constructs; (iii) growth under low serum conditions; (iv) capacity to form colonies in soft agar; and (v) capacity to form tumors after subcutaneous inoculation into athymic nude mice. Changes in morphology and growth pattern of transfected NIH3T3 cells
Four separate colonies for TFE3PRCC (clones C1-D3, C1-D4, C1-D5, C1.9), three for the reciprocal fusion product PRCCTFE3 (rec1, rec7, recC5), and three transfectants containing both constructs (C1+rec5, C1+rec10, C1+recB6; abbreviated as CR5, CR10 and CRB6) were selected for further analysis. Two colonies containing the empty vector were taken as negative controls (A5,A6). NIH3T3 cells transfected with dierent constructs clearly showed dierent morphologies ( Figure 1 ). PRCCTFE3 transfected cells grew more densely than the other transfectants and showed partial loss of contact inhibition. Their form was more elongated than that of the cells transfected with the reciprocal product or the combination of both. In contrast, all TFE3PRCC transfected cells demonstrated a spiky-like appearance, most clearly seen in C1-D3 and C1-D4. All double transfectants were larger and showed a tendency to grow in isolated groups ( Figure 1 ). The morphology of the negative controls appeared to be most similar to that of the PRCCTFE3 transfectants.
Expression of fusion transcripts in transfected NIH3T3 cell lines
Based on the fact that the human TFE3PRCC and PRCCTFE3 fusion mRNAs are of nearly the same size as the wildtype human and mouse PRCC and TFE3 mRNAs, respectively, and that preliminary Northern blot experiments indicated that the expression levels of the fusion constructs were relatively low, RT ± PCR analysis was chosen as a method to examine the presence and level of the exogenous PRCCTFE3 and TFE3PRCC mRNAs. In order to be able to perform these analyses in a semi-quantitative manner, PCR was performed using dierent numbers of cycles (20, 25 and 30) . As controls, mouse Gapdh mRNA and endogenous Tfe3 and Prcc mRNAs were also PCR ampli®ed in the same way (not shown). Expression of TFE3PRCC was clearly lower in all cell lines transfected with the TFE3PRCC construct than in the t(X;1)-positive tumor cells, except for double transfectant CR10 which showed an expression level comparable to that in t(X;1)-positive tumor cells. Expression of the reciprocal translocation product, PRCCTFE3, was comparable to the expression observed in t(X;1)-positive tumor cells (not shown). Mouse endogenous Tfe3 and Prcc genes were expressed in all cell lines.
Growth of NIH3T3 transfectants under low-serum conditions
Since growth in the absence of exogenous growth factors is another characteristic of transformed cells, all transfectants were tested for their ability to grow under low-serum conditions (1 and 5% FCS). As can be seen in Figure 2 , NIH3T3 cells transfected with PRCCTFE3 Figure 1 Morphological changes in NIH3T3 transfected PRCCTFE3 clones rec1, rec7 and recC5, TFE3PRCC clones C1-D3, C1-D4, C1-D5 and C1.9, double transfectants CR5, CR10 and CRB6, and negative controls A5 and A6
(rec1,7,C5) grew fastest and to the highest densities in both cases. The growth rate and density of the other transfectants were invariably lower. The dierences in numbers of cells when reaching con¯uency between the PRCCTFE3 transfectants on one hand and the other transfectants on the other hand was mainly due to their ability to grow to higher densities.
Anchorage-independent growth of isolated colonies
To examine the ability of the recovered transfectants to again form colonies in soft agar, 100 000 and 50 000 cells were seeded in duplo onto soft agar dishes. Microscopic analysis was performed 16 days after plating. Since morphology and size of the colonies that were formed varied between the dierent transfectants, the colonies were analysed by measuring the area occupied by the colonies in conjunction with a computerized count of the number of colonies. Typical images of the soft agar colonies formed by the dierent transfected clones are shown in Figure 3 . The numbers of colonies, plating eciencies, mean areas per colony and the total surface areas occupied by the colonies are displayed in Table 2 . The largest colonies were observed for PRCCTFE3 transfectants rec1, rec7 and rec-C5, and TFE3PRCC clone C1.9. All double transfectants formed remarkably smaller colonies. The number of colonies formed was also high for PRCCTFE3 transfectants rec1, rec7 and rec-C5. Even higher colony numbers were observed for the double transfectants (CR5, CR10, CR-B6). However, the cells in many of these colonies seemed loosely attached to one another ( Figure 3 ). This eect was also observed in the initial clonogenic assay (see above). Statistical analysis (using the original counts of 25 squares per duplo per clonal cell line; Student t-test) demonstrated signi®cantly more colonies when comparing all PRCCTFE3, all TFE3PRCC, or all double transfectants with both negative controls (for P values: see legend of Table 2 ). The double transfectants yielded signi®cantly more colonies than either single transfectant only when plating 100 000 cells. PRCCTFE3 transfectants produced signi®cantly more colonies than TFE3PRCC transfectants. Since microscopic analysis comprises all colonies, large or small, and it can be argued that only large colonies should be counted which would represent truly transformed cells (and would have been visible in macroscopic counts), the total area occupied by the colonies was also used as a parameter for anchorage independent growth (taking into account both number and size of the colonies). PRCCTFE3 transfectants again occupied a signi®-cantly larger area than negative controls (for P values see legend Table 2 ), double transfectants, and TFE3PRCC transfectants (0.025P50.05). All transfectants showed a signi®cant larger total area than the negative controls.
In vivo tumor formation by transfected NIH3T3 cells
In order to establish whether the dierent NIH3T3 transfectants were also able to form tumors in vivo, 10 5 and 10 6 cells were inoculated into the left and right ank of athymic nude mice, respectively. Tumor growth per clone (the mean value of the tumors in three mice) for both inoculations of 10 5 and 10 6 cells is shown in Figure 4 . For all three PRCCTFE3 clones (rec1, rec7 and rec-C5) and for one of the transfectants with TFE3PRCC (clone C1-D4) tumor growth was readily observed within 1 week at the site where 10 6 cells were inoculated, and after 2 weeks at the site where 10 5 cells were inoculated. Due to the rapidly increasing size of these tumors, these mice were sacri®ced after about 6 weeks. One of the three mice inoculated with PRCCTFE3 clone rec1 died as a result of accumulation of ascites¯uid at 29 days after inoculation. In a later stage, tumors also arose in mice inoculated with clones C1-D3 (2.5 weeks after Transformation by PRCCTFE3 and TFE3PRCC fusion genes MAJ Weterman et al inoculation of 10 6 cells) and after extensive lag phases also in those mice inoculated with clones C1-D5 and C1.9 (approximately 3.5 weeks after inoculation of 10 6 cells). After approximately 4 weeks, some growth was also observed for one of the negative controls (A5; all mice at the site of inoculation of 10 6 cells). This growth was signi®cantly slower than that caused by the PRCCTFE3 clones, or TFE3PRCC clone C1-D4. To our surprise, the double transfectants initially did not show any tumor growth at all. Only after 6 weeks, two out of nine mice inoculated with both fusion constructs showed tumor development (clone CR10, mouse 28 and mouse 30) (Figure 4 , middle panels). At day 74, all mice were sacri®ced except for those inoculated with the double transfectants still not showing any signs of tumor growth. After 2 ± 3 months, tumors were visible in most double transfectants, except for one mouse inoculated with clone CR5. Remarkably, tumors in two of these mice developed ®rst at the site where 10 5 cells had been inoculated, and only a small tumor or no tumor at all was detected at the site of 10 6 cells. However, once a tumor developed, the growth rate was comparable to that observed for the PRCCTFE3 transfectants. Growth of the tumors of all double transfectants is shown in Figure 4 (middle panel). For comparison, the growth curves of the tumors of one of the rec7 clones (mouse 1) are included in this graph.
After dissection, the tumors were analysed by RT ± PCR for expression of the exogenous fusion genes, the endogenous Tfe3 and Prcc genes, and the control Gapdh gene in the same manner as initially used for the cell lines. The results are presented in Figure 5 . The expression levels of TFE3PRCC were highest in the double transfectant clone CR10 (lanes 28 ± 32), and TFE3PRCC clones C1-D3 and C1-D4 (lanes 10 ± 15) and comparable or higher than those of wildtype Prcc. However, most clones showed a lower level of expression of TFE3PRCC than that in t(X;1)-positive tumor cells (right panel of Figure 5 ). The highest expression of the reciprocal fusion product PRCCTFE3 was found in clones rec1, rec7 and rec-C5 (lanes 1 ± 9) and in double transfectant clone CR10 (lanes 28 ± 32). Expression of PRCCTFE3 in the Values for the duplos are given separtely between brackets. The total colony area is based on the sum of both duplos. Comparison of the mean number of colonies per counted square (25 squares per duplo) revealed signi®cant dierences at both densities plated using Student t-test for the negative controls (A5+A6) with all PRCCTFE3 (rec1+rec7+recC5), all TFE3PRCC (C1-D3+C1-D4+C1-C5+C1.9) clones, and all double transfectants (CR5+CR10+CRB6) (P50.001 in all cases). At high density i.e. 100 000 cells plated, the double transfectants produced signi®cantly more colonies than either single transfectant (P50.001). At low density i.e. 50 000 cells plated, the dierence was only signi®cant with the TFE3PRCC clones (P50.001). The PRCCTFE3 clones produced signi®cantly more colonies per counted square than the TFE3PRCC clones at both densities (P50.001). When examining the total area per petridish (two measurements per clonal cell line) using a Student t-test, signi®cant dierences were found at low density for the negative controls as compared to all TFE3PRCC clones (0.015P50.02), all PRCCTFE3 clones (P50.001), and all double transfectants (0.0015P50.01), and at high density for the negative controls as compared to all TFE3PRCC clones (P=0.2), all PRCCTFE3 and all double transfected clones (both P50.001). The PRCCTFE3 transfected clones occupied a larger area than the double transfected clones (0.0015P50.01 at low density, P50.001 at high density), and the TFE3PRCC transfected clones (borderline signi®cance; 0.025P50.05 at both densities). The dierence in total area was not signi®cant between TFE3PRCC and double transfectants tumors caused by the single transfectants was comparable to the endogenous expression of wildtype Tfe3.
Since the tumors of the double transfectants developed only after extended lag phases, expression levels in the tumors arising on the left and right¯ank were analysed separately. However, no obvious dierences in expression were noted between these tumors.
Changes in growth and morphology of PRCCTFE3-and TFE3PRCC-transfected conditionally immortalized kidney cells
Since papillary renal cell cancers are thought to develop from the proximal tubules within the kidney we generated conditionally immortalized cell lines from the kidney proximal tubules of a transgenic H-2Kb-tsA58 mouse. When incubated under permissive conditions (328C with the addition of interferon-g to the culture medium), these cells can be grown inde®nitely due to expression of the SV40 large Tantigen. Under non-permissive conditions (378C, without interferon-g) growth arrest occurs and the morphology of the cells changes markedly. To exclude the possibility that the results obtained with NIH3T3 cells, indicating that PRCCTFE3 transfected cells showed most characteristics associated with malignant transformation, were due to clonal variation or speci®c parental background, we stably transfected two conditionally immortalized kidney cell lines with expression constructs containing PRCCTFE3 and/or TFE3PRCC cDNAs. A pool of at least 25 transfected clones was used per expression construct to assay cell growth and dierentiation under non-permissive conditions. Empty vector transfected cells were taken as negative controls. Growth arrest was observed after 1 ± 2 weeks for all transfected cells except for those transfected with PRCCTFE3. After approximately 3 weeks, marked changes in morphology occurred in all (Weterman et al., 1996b) , t(X;1)-positive CL89-17872 renal carcinoma cells (41) (Weterman et al., 1996a) , and a human embryonal kidney cell line (293) (42) transfected cells except for the PRCCTFE3 transfectants as illustrated in Figure 6 . PRCCTFE3 transfected cells (Figure 6a,b) were relatively large and irregular in shape and grew partially on top of each other whereas in all other transfectants the cells showed epithelial-like morphology, and formed elongated, rounded and nicely aligned structures (Figure 6c ± h ).
Discussion
In order to determine whether the fusion genes TFE3PRCC and PRCCTFE3, formed as a result of the papillary renal cell carcinoma-associated t(X;1)(p11;q21) translocation, are able to confer malignant transformation onto other cell types, expression constructs containing the corresponding cDNAs were used to transfect non-malignant rat-1 or NIH3T3 cells. After transfection, the ability of these cells to grow in an anchorage-independent manner was assayed through colony formation in soft agar. At high densities the largest numbers of colonies were observed for the cells transfected with both fusion constructs. However, these colonies were morphologically dierent from and smaller than colonies formed by cells transfected with the translocation products separately. The formation of these aggregates was not seen for the single transfectants. At higher densities these aggregates might be formed more easily and might facilitate the outgrowth of colonies. Alternatively, paracrine substances might be secreted as a result of the transfection of one product which might be stimulatory at a certain threshold level for cells transfected with the reciprocal translocation product. NIH3T3 PRCCTFE3 transfectants consistently showed relatively high yields at all densities. Rat-1 TFE3PRCC transfectants showed slightly better yields than rat-1 PRCCTFE3 transfectants, albeit at levels barely above background.
Since dierences between positive and negative controls were very small for rat-1 cells, several NIH3T3 colonies transfected with PRCCTFE3, TFE3PRCC, or both fusion constructs were examined for characteristics associated with malignant transformation. Cells transfected with dierent constructs clearly showed dierent morphologies and growth patterns. When comparing the phenotypes of PRCCTFE3 transfected with TFE3PRCC transfected clones, we observed that the PRCCTFE3 clones hardly displayed any contact inhibition of growth, leading to relatively high cell densities. This observation was con®rmed in the growth assays under low-serum conditions. When reassaying recovered individual colonies for anchorage-independent growth, all PRCCTFE3 clones and two of the four TFE3PRCC clones showed relatively large total areas occupied by colonies (based on both number and size of the colonies formed). The clones transfected with both fusion products showed high plating eciencies, but the size of these colonies was relatively small. Although soft agar assays are often used as a measure for malignant transformation, the results do not necessarily correspond with the ability of the transfected cells to form tumors in vivo. In Ewing sarcomas, for example, several chimeric transcription factors such as EWS/FLI1 and EWS/ETV1 are thought to modulate aberrant gene expression leading to tumorigenesis (Thompson et al., 1999) . Although both fusion products were able to confer a common tumorigenic phenotype onto NIH3T3 cells as measured by tumor formation in SCID mice, only one of them (EWS/FLI1) was able to form colonies in soft agar. In Figure 6 Morphology of conditionally immortalized kidney cells transfected with PRCCTFE3 (a,b), TFE3PRCC (c), PRCCTFE3 and TFE3PRCC (d,e), pEGFPN3 (f), pEGFPN3 and pcDNA3.2-hygro (g), and pcDNA3.2-hygro (h). Structures shown in c ± h were observed for all transfected cells except for those transfected with PRCCTFE3 only our case, a combination of number and size of the colonies formed in soft agar turned out to be predictive of tumorigenicity in athymic nude mice. In mice that were inoculated with the PRCCTFE3 transfectants, or TFE3PRCC transfected clone C1-D4, tumors developed shortly after inoculation. In addition, these tumors grew rapidly. Two other TFE3PRCC transformed clones (C1-D5 and C1.9) only formed tumors after extended lag phases. This may be explained by the fact that the TFE3PRCC expression levels in the tumors formed by these two clones were relatively low ( Figure 5) . Furthermore, it has to be noted that, in contrast to PRCCTFE3, the expression level of TFE3PRCC was lower in all TFE3PRCC transformed clones than that in t(X;1)-positive tumor cells, which may account for the less malignant phenotype of the TFE3PRCC transfected clones.
Since both exogenous translocation products were expressed at levels equal to or lower than those in t(X;1)-positive tumor cells, and comparable to those of endogenous Tfe3 and Prcc, tumor formation cannot simply be explained by overexpression of the translocation products in the clones displaying a higher tumorigenic capacity. Secondary changes alone, which can be triggered when culturing these cells under stressful conditions, obviously cannot account for the rapid formation of tumors resulting from inoculation of all PRCCTFE3-positive clones, since virtually no tumor growth was observed for the empty vector controls in the same period. In addition, morphological transformation clearly distinguished cells transfected with dierent constructs which is an indication of the speci®c eect of the transfected translocation products.
Transfection studies using conditionally immortalized cells derived from the kidney proximal tubules of an H-2Kb-tsA58 transgenic mouse revealed that cells transfected with the PRCCTFE3 expression construct did not show growth arrest or changes in morphology which was observed for all other transfectants after transfer to the non-permissive temperature. Studies on chromosomal translocations in tumors leading to gene fusions have revealed that in most cases one of the two fusion products is particularly crucial for tumor development. Mostly, this is due to the fact that one of the translocation products is relatively small and does not contain the domains relevant for its function, whereas the reciprocal fusion protein has retained most or all of these domains. In case of the t(X;1) translocation, one fusion protein, PRCCTFE3 contains the DNA-binding and dimerization domains of TFE3 in addition to a moiety of PRCC which may function as a transactivation domain (Weterman et al., 2000) , whereas the reciprocal fusion protein TFE3PRCC contains no known protein motifs. Taking all assays into account, PRCCTFE3 may be considered the most potent transforming one of the two translocation products. This is in line with our earlier notion that the transactivation capacity of PRCCTFE3 is signi®-cantly altered whereas that of TFE3PRCC is comparable to that of wildtype PRCC (Weterman et al., 2000) .
Since both fusion proteins can induce transformation, one might expect that cells transfected with both products would behave most aggressively. Unexpectedly, we found that the double transfectants did not form any tumors in nude mice in the period in which most single transfectants did, including the negative empty vector controls. RT ± PCR analysis of the tumors which arose after extended lag phases in mice inoculated with doubly transfected cells, showed that both fusion genes were expressed. Therefore, a scenario in which either one should be lost in order for a tumor to develop can be excluded. One explanation for the extended lag phases might be the lower PRCCTFE3 expression levels in these transfectants, as measured by semiquantitive RT ± PCR. If so, this might indicate that PRCCTFE3 is more crucial for tumor development. In contrast, the expression level of the reciprocal product TFE3PRCC was enhanced in the tumors as compared to the corresponding cell lines containing both expression constructs, pointing at a transforming role for this fusion protein as well. Transfection of both constructs into conditionally immortalized mouse kidney cells could not alleviate the growth arrest induced by transfer to the non-permissive temperature whereas single PRCCTFE3 transfectants were able to bypass this growth arrest. This is in line with our earlier observation of extended lag phases in the tumor formation of mice inoculated with double transfected cells which awaits further investigation. A similar phenomenon has been described by others when examining tumor-promoting properties in nude mice of the acute leukemia translocation t(3;21)-associated AML1/EAP and AML/MDS1 fusion genes. Cells transfected with both AML1/EAP and AML1/MDS1 produced tumors that were signi®cantly smaller than those caused by the empty vector-transfected cells which, in turn, were signi®cantly smaller than those of the AML1/MDS1 transfected cells (Zent et al., 1996) . In conclusion, it is clear that although both fusion proteins may contribute to cellular transformation, PRCCTFE3 appears to be crucial for the transformation of kidney cells and may therefore be the t(X;1)-associated fusion protein that is critical for the development of papillary renal cell carcinomas.
Materials and methods
Cell culture and transfection NIH3T3 cells were grown as monolayers in Dulbecco's Modi®ed Eagle Medium (DMEM) (GIBCO, Life Technologies) supplemented with 10% fetal calf serum (FCS) and antibiotics (PenStrep; 100 U/ml penicillin, 100 mg/ml streptomycin). Transfections were performed using Fugene (Boehringer Mannheim) according to the protocol of the manufacturer. One ml of Fugene per 2 mg of expression construct DNA, containing the cDNAs of the fusion genes cloned out of frame to GFP into pEGFP-N3 (Clontech), was used for approximately 2 ± 5610 6 cells. Stable transfectants were selected in the presence of 0.3 mg/ml G418 in the culture medium. Digital images of the cells were captured using the processing software program NIH Image v159.
Soft agar assay
After transfection, cells were grown in the presence of G418 for 2.5 weeks. Pools of stable transfectants or clonal transfected cell lines were harvested and aliquots were added to 60 mm dishes in duplo containing 1.2% methylcellulose in complete culture medium (50% DMEM+10%FCS/50% F10+10%FCS containing 0.3 mg/ml G418) on top of a layer of 0.5% agar in DMEM/10%FCS. As a positive control, transfectants with a construct containing an activated RAS allele (Leu61) (generously provided by Dr J Bos, Utrecht, the Netherlands) were included. Cells transfected with the vector pEGFP-N3 were included as negative controls. In the ®rst soft agar assay, aliquots of 50 000, 100 000 and 150 000 cells were plated in duplo. Microscopic analysis was performed after 24 days. Twenty squares of 0.25 cm 2 of the NIH3T3 dishes and nine squares of the rat-1 dishes were examined for the presence of colonies. The second soft agar colony assay with clonal transfected cell lines was performed by plating 50 000 and 100 000 cells in duplo. After 16 days, a computerized count of 25 squares of 1.9 mm 2 was carried out. In order to estimate the mean size of the colonies, measurement of the area occupied by the colonies was determined using the NIH Image software processing program.
Low-serum growth assay
Aliquots of 10 5 cells were plated in duplo onto 600 mm dishes and grown in DMEM supplemented with antibiotics and 1 or 5% FCS. Each day, two dishes per cell line were harvested and counted. The assay was continued until con¯uency.
In vivo tumorigenicity assay 10 5 and 10 6 transfected cells were subcutaneously inoculated into the left and right¯ank of 47 day old female athymic nude mice, respectively. Three mice per transfected cell line were inoculated. After inoculation, mice were checked for tumor growth at least once a week. Once tumors were palpable, tumor sizes were measured twice a week. The mice were sacri®ced when tumor growth started to interfere with the health of the animals. The mice were inoculated as follows: mouse 1 ± 9: PRCCTFE3 transfected clones, rec7 (1 ± 3), rec1 (4 ± 6), rec-C5 (7 ± 9), mouse 10 ± 21: TFE3PRCC transfected clones C1-D3 (10 ± 12), C1-D4 (13 ± 15), C1-D5 (16 ± 18), C1.9 (19 ± 21), mouse 22 ± 30: PRCCTFE3 and TFE3PRCC transfected clones CR5 (22 ± 24), CR10 (25 ± 27), CR-B6 (28 ± 30), mouse 34 ± 39: empty vector-transfected clones A5 (34 ± 36) and A6 (37 ± 39).
Expression analysis
Total RNA of tumor tissue was isolated according to Auray and Rougeon (1980) . RNA extractions of the cell lines were performed using RNAzol (Campro Scienti®c). Semiquantitative RT ± PCR was carried out using 7.5 mg total RNA, superscript RT (Life Sciences), random hexamer primers for priming, and speci®c primer pairs in the PCR reaction. The PRCCTFE3 primers used were: prePRCC1.for: 5'-GCC TCA ATC TGC CCC CTC CAA T-3' and postTFE3-1.rev: 5'-CTC TGA GCT GGA CCC GAT GGT GA-3'. The TFE3PRCC primers used were: preTFE3-2.for: 5'-CAG GAC CCC TGC CAT GTC GTC A-3' and postPRCC-2: 5'-TGA TAG CAG AGG GCG ACG GAG T-3'. Primers for endogenous mouse Tfe3 detection were: mTFE3for: 5'-GCC TCA CCA GCC ATC TCT GTG ATT-3' and mTFE3rev: 5'-CTC TGA GCT GGA CCC GAT GGT GA-3' and primers for endogenous mouse Prcc detection were: mPRCCfor: 5'-CAA GGC CCT GGG CTC AGT CTG C-3' and mPRCCrev: 5'-AAC TCA AGG GGG GCA TTG GCT-3'. As a control, RT ± PCR was also performed using mouse speci®c Gapdh primers: mGAPDHfor: 5'-GGT GAA GGT CGG TGT GAA CG-3' and mGAPDHrev: 5'-CAA AGT TGT CAT GGA TGA CC-3'. PCR reactions were carried out using 20, 25 and 30 cycles. The samples were denatured at 948C for 2 min. Subsequently, 20 ± 30 cycles were performed of denaturation (30 s at 948C), annealing (30 s), and extension (40 s at 728C). Annealing temperatures were 608C for PRCCTFE3, 618C for TFE3PRCC and endogenous Tfe3, 658C for endogenous Prcc, and 508C for Gapdh. Aliquots were size fractionated on a 1% agarose gel.
Establishment and transfection of conditionally immortalized renal epithelial cells
The kidneys of a male transgenic H-2Kb-TsA58 mouse 6 months of age were surgically removed. Proximal tubuli were isolated out of slices of the kidney and 2 ± 3 tubuli were transferred to K1 medium supplemented with interferon-g (10 U/ml) in 24-and 96-well plates which were coated with collagen. K1-medium consists of a 1 : 1 mixture of DMEM and Ham's F12 medium, supplemented with gentamycin (50 mg/ml), 10 ml/ml nonessential aminoacids, insulin (5 mg/ ml), transferrin (5 mg/ml), Na 2 SeO 3 (50 nM), hydrocortisone (50 nM), triiodothyronine (5 pM), prostaglandin E1 (50 nM), and FCS (5%). After 2 weeks of incubation at 328C, growth was observed. When growth was clearly present, the cells were transferred to 6-well plates without collagen coating. The medium was gradually replaced by DMEM/10% FCS supplemented with PenStrep and interferon-g. At this stage, cells were diluted to obtain a one cell per well concentration. Those wells containing one cell were selected. Colonies arising in these wells were allowed to grow.Two independent clonal cell lines obtained in this way were used for the transfection assays. To assess the origin of the cultured cells on the renal tubule, rt-PCR for two markers speci®c for proximal tubuli within the kidney, aminopeptidase A and peptidylpeptidase IV, was performed which con®rmed that the cells were derived from the proximal tubules. Transfection was performed with 30 mg of the expression constructs (PRCCTFE3 in pcDNA3.1-Hygro (Invitrogen), TFE3PRCC in pEGFP-N3 (Clontech) or both) using Fugene (Roche). Transfections with the empty vectors (pEGFP-N3, pcDNA3.1-Hygro or both) were taken as negative controls. Stable transfectants were selected in the presence of 300 mg/ ml G418 and/or 400 mg/ml hygromycin-B. The morphology of the cells was examined using a Zeiss 135 TV microscope with a¯uotar objective.
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